Home › NDC Lookup › RxCUI directory › RxCUI 1665449

Cefuroxime 750 MG Injection — RxCUI 1665449

Name: Cefuroxime 750 MG Injection (RxCUI 1665449)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1665449 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1665449

Official nameCefuroxime 750 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped8

Package NDCs mapped8

Reported Medicaid activity (SDUD)465 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cefuroxime: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Cefuroxime treats a wide range of bacterial infections. In tablet form — sold as Cefuroxime Axetil — it's used for things like strep throat, sinus infections, ear infections in kid...
What kinds of infections does cefuroxime treat?
You can take Cefuroxime Axetil tablets with or without food — both work. That said, taking it with food does improve how much your body absorbs, so if your stomach tolerates it, a...
Should I take the tablet with food or on an empty stomach?

📖 Read our full Cefuroxime guide →

🕸️ Concept Web — How Cefuroxime 750 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Cefuroxime 750 MG Injection RxCUI 1665449 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Cefuroxime 2194 IN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Cefuroxime Injection 1665443 SCDF
- Cefuroxime Injectable Product 1152109 SCDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Cefuroxime 750 MG 1665448 SCDC

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Cefuroxime 750 MG SCDC · 1665448
Cefuroxime Injection SCDF · 1665443
Cefuroxime Injectable Product SCDG · 1152109

📦 FDA Products & Package NDCs

8 products · 8 package NDCs

8 package NDCs map to RxCUI 1665449 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9567-25	25 VIAL in 1 CARTON (0143-9567-25) / 1 INJECTION, POWDER, F...	Cefuroxime	Hikma Pharmaceuticals USA Inc.	2004-01-09
00143-9568-25	25 VIAL in 1 CARTON (0143-9568-25) / 1 INJECTION, POWDER, F...	Cefuroxime	Hikma Pharmaceuticals USA Inc.	2004-01-09
00143-9977-22	25 VIAL in 1 CARTON (0143-9977-22) / 1 INJECTION, POWDER, F...	Cefuroxime	Hikma Pharmaceuticals USA Inc.	2004-01-09
00143-9979-22	25 VIAL in 1 CARTON (0143-9979-22) / 1 INJECTION, POWDER, F...	Cefuroxime	Hikma Pharmaceuticals USA Inc.	2004-01-09
00264-3112-11	24 CONTAINER in 1 CASE (0264-3112-11) / 50 mL in 1 CONTAINE...	Cefuroxime and Dextrose	B. Braun Medical Inc.	2001-02-21
00264-3114-11	24 CONTAINER in 1 CASE (0264-3114-11) / 50 mL in 1 CONTAINE...	Cefuroxime and Dextrose	B. Braun Medical Inc.	2001-02-21
25021-0118-10	25 VIAL in 1 CARTON (25021-118-10) / 1 INJECTION, POWDER, F...	Cefuroxime sodium	Sagent Pharmaceuticals	2016-09-01
25021-0119-20	25 VIAL in 1 CARTON (25021-119-20) / 20 mL in 1 VIAL	Cefuroxime sodium	Sagent Pharmaceuticals	2016-09-01

Observed labelers: Hikma Pharmaceuticals USA Inc. (4) · B. Braun Medical Inc. (2) · Sagent Pharmaceuticals (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0697	Sterile cefuroxime injection	6	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.